Breadcrumb

What's New at the RI-MUHC ?

RI-MUHC leads study to identify a novel mechanism driving aggressive prostate cancer

This international research collaboration may lead to a shift in the clinical management of patients...

Improving the performance of rapid tests through clear instructions

Researchers at the RI-MUHC investigate whether rapid antigenic detection tests for COVID-19 could be adequately used in the workplace.

Stress in healthcare workers: a model to help us rethink challenges

Better understand for better support: a new model developed by RI-MUHC researchers illustrates the relationships between the various factors...

COVID-19 vaccination highly effective in individuals with immune-related inflammatory diseases

RI-MUHC researcher Sasha Bernatsky is senior author of a nationwide study

$6.7 million to study the impacts of COVID-19 on children

Health Minister Jean-Yves Duclos visits Montreal to announce a new investment in pediatric research and to congratulate researcher...

Immunotherapy showing significant advancements in lung cancer treatment

Phase 3 clinical trial of neoadjuvant nivolumab leads to practice-changing results

Benefits of fluvoxamine confirmed in new study

Preventing hospitalization following COVID-19 infection in vulnerable populations

The unexpected role of chloride channels in a rare neurological disorder

A new study finds mutations affecting the chloride channel of a glutamate transport protein in a rare disorder...

Where immune cells are located is critical for cancer immune therapy, a new study shows

An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a...

Learn more about the RI-MUHC